Biotech Values

[exwannabe]

RE: memory Pharma.

"The 50 mg group also showed no statistically significant differences favoring treatment at any endpoint in the study."

Since in other places they didn't include the "favoring treatment" clause, one must assume that some endpoints were stat sig in favor of placebo.

There are actually 9 primary endpoints (3 arms, 3 points each) and we see 2 hit stat sig. What about the rest?

Sounds like the data is a little murkier than let on.

It woud be nice if companies would just present a table with all endpoint data, I guess I live in a fantasy world though.